Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult (18 years of age or older)
Able to undergo routine cystoscopy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0 and day 5
Awards & highlights
Study Summary
This study is evaluating whether a new injection needle is safe and effective for treating overactive bladder.
Eligible Conditions
- Overactive Bladder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 0 and day 5
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 and day 5
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Procedure Success
Secondary outcome measures
Adverse Events during Procedure
Patient Tolerance of Injection
Trial Design
1Treatment groups
Experimental Treatment
Group I: Repris NeedleExperimental Treatment1 Intervention
Reprise sheath and needle
Find a Location
Who is running the clinical trial?
Uro-1 MedicalLead Sponsor
2 Previous Clinical Trials
90 Total Patients Enrolled
Thomas Lawson, PhDStudy DirectorUro-1 Medical
2 Previous Clinical Trials
62 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger